Public comment on the new guidelines from the U.S. Preventative Services Task Force is open through May 8.
By Laura Santhanam
Men hoping to avoid some side effects of prostate cancer treatment are shelling out tens of thousands of dollars for a procedure whose long-term effects are unknown and insurers, including Medicare, won’t pay for.
By Julie Appleby, Kaiser Health News
A recent study, published online by the Journal of Men’s Health, indicates an increased risk for prostate cancer in male cyclists over the age of 50.
By Nora Daly
The U.S. Preventive Services Task Force said Friday that prostate specific antigen tests, known as PSAs, that are done to detect prostate cancer could be doing more harm than good. Jeffrey Brown discusses the latest controversial recommendation from the influential…
In other news Wednesday, three suicide bombings in Iraq killed at least 32 people, just four days before national elections, and President Obama signed a stop-gap extension of jobless benefits after a budget impasse in the Senate.
By PBS NewsHour
New cancer rates in the United States have declined for the first time and the cancer death rate among men and women has continued to drop, according to an annual report on cancer published Tuesday in the Journal of the…
Medical care for older men may change after a federal task force recommended Monday that men older than 75 not get screened for prostate cancer, the second-deadliest-type among males. A National Institutes of Health official presents the concerns behind the…
The chemical bisphenol A, known as BPA, is used to make many common plastic products used in U.S. homes, including baby bottles. Scientists and expert panels have been tasked with determining whether BPA has adverse effects on human health.
The American Cancer Society reported Wednesday that cancer deaths in the United States fell in 2004 for the second straight year due to better screening and fewer smokers. Dr. Harmon Eyre, chief medical officer of the American Cancer Society, explains…
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.